Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $242

تينيت للرعاية الصحية

Tenet Healthcare Corporation

THC

0.00

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE: THC) with a Buy and lowers the price target from $252 to $242.